Q3 2026 Portfolio in Review
Somehow, we’re already heading into the final stretch of 2026 (where did the year go?). This past quarter brought a lot of momentum across the Version One family — from new investments and product launches to some very well-deserved recognition. As always, this is just a snapshot of what we can share publicly (there’s plenty […]
Q2 2026 Portfolio in Review
Somehow, we’re already halfway through 2026 — and it’s been a busy quarter. Q2 brought a steady stream of exciting updates from across the portfolio, including major milestones, new launches, fundraising wins, and a few viral moments. We’re happy to share a handful of highlights from the quarter, knowing this is just a snapshot of […]
We’re Bio-Bullish
For over a decade, we’ve been spending time in health and bio. It’s a category we’ve been watching closely. In the early days, we wrote a lot about the space – from healthcare marketplaces to the role of genomics in personalized medicine. And we made a handful of investments in tools and diagnostics like: Gencove […]
Announcing our investment in GridBank
Today, we’re excited to announce that we’ve co-led the $6M seed round of GridBank, a company building the global transaction network for real-world data. At its core, GridBank turns every smartphone into a data node, enabling people to capture and sell real-world video, images, and location-tagged media to companies that need it. Pricing is dynamic […]
Q1 2026 Portfolio in Review
We’re a quarter of the way through 2026, and the V1 family is off to a fast start. Across the portfolio, teams are building with urgency, laying the groundwork for what we expect to be another strong year ahead. Before we get too far into Q2, we wanted to take a moment to share a […]